Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis

Authors

Lisa M. Avery, St. Joseph's Health
Catherine B. Felberbaum, Rochester Regional HealthFollow
Muhammad Hasan, St. Joseph's Health

Department

Pharmacy

Document Type

Article

Publication Title

IDCases

Abstract

Prosthetic valve endocarditis due to Cardiobacterium hominis is rare and recommended therapy includes a third generation cephalosporin. We report a case of Cardiobacterium hominis endocarditis post transcatheter aortic valve replacement in a patient with significant beta-lactam antimicrobial sensitivities who was successfully treated with ciprofloxacin monotherapy in conjunction with surgery.

First Page

77

Last Page

79

DOI

10.1016/j.idcr.2018.01.016

Volume

11

Publication Date

2-6-2018

PubMed ID

29619328

Recommended Citation

Avery, L. M., Felberbaum, C. B., & Hasan, M. (2018). Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis. IDCases, 11, 77-79. https://doi.org/10.1016/j.idcr.2018.01.016